about
DNA demethylating antineoplastic strategies: a comparative point of viewDihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
I Bagaloni
@en
I Bagaloni
@nl
type
label
I Bagaloni
@en
I Bagaloni
@nl
prefLabel
I Bagaloni
@en
I Bagaloni
@nl
P31
P496
0000-0002-7788-230X